SCHEMBL5780703

SCHEMBL5780703

CCc1cc(Br)ccc1S(=O)(=O)Nc1ccc2c(c1)CCNCC2

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR6 P50406 4/20 0.54
HTR2C P28335 6/20 0.54
DRD2 P14416 3/20 0.54
HTR2A P28223 3/20 0.54
DRD3 P35462 3/20 0.54
MLNR O43193 2/20 0.54
MELK Q14680 1/20 0.46
HTR2B P41595 3/20 0.45
LMNA P02545 3/20 0.41
SMN1; SMN2 Q16637 2/20 0.41
ALDH1A1 P00352 2/20 0.41
THRB P10828 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
NPSR1 Q6W5P4 1/20 0.40
PNMT P11086 2/20 0.40
ASIC3 Q9UHC3 1/20 0.40
POLB P06746 1/20 0.39
TRIM24 O15164 1/20 0.39
SLC6A9 P48067 1/20 0.39
CYP1A2 P05177 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5782587 0.78 ALPL (0.55) HTR6HTR2CDRD2HTR2ADRD3
SCHEMBL14433513 0.76 SMN1; SMN2 (0.52) LMNASMN1; SMN2ALDH1A1POLBSLC6A9
SCHEMBL10360424 0.74 HTR6 (0.66) HTR6HTR2CDRD2HTR2ADRD3
Hydrochloric Acid SCHEMBL7014506 0.72 HTR6 (0.64) HTR6HTR2CDRD2HTR2ADRD3
SCHEMBL1946627 0.71 LMNA (0.77) HTR6HTR2CDRD2HTR2ADRD3
SCHEMBL5780847 0.71 HTR6 (0.59) HTR6HTR2CDRD2HTR2ADRD3
SCHEMBL5781306 0.71 HTR6 (1.00) HTR6HTR2CDRD2HTR2ADRD3
SCHEMBL13362013 0.71 HTR6 (0.58) HTR6HTR2CDRD2HTR2ADRD3
SCHEMBL14433971 0.70 LMNA (0.51) HTR6LMNASMN1; SMN2THRBPOLB
SCHEMBL3328984 0.70 HTR6 (0.61) HTR6HTR2CDRD2HTR2ADRD3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1487801-B1 7-ARYLSULFONAMIDO-2,3,4,5-TETRAHYDRO-1H-BENZO¬D|AZEPINE DERIVATIVES WITH 5-HT6 RECEPTOR AFFINITY FOR THE TREATMENT OF CNS DISORDERS GLAXO GROUP LTD (GB) 2006-04-19 EP claimed
US-20050090496-A1 Sulphonyl compounds with 5-ht6 receptor affinity GLAXO GROUP LIMITED (GB) 2005-04-28 US claimed
US-20050090485-A1 7-Arylsulfonamido-2,3,4,5-tetrahydro-1h-benzo'diazepine derivatives with 5ht6 receptor affinity for the reatment of cns disorders GLAXO GROUP LIMITED (GB) 2005-04-28 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050090496-A1 Sulphonyl compounds with 5-ht6 receptor affinity HTR6, HTR4, HTR5A HTR6 1/4885HTR2C 8/4885DRD2 64/4885
US-20050090485-A1 7-Arylsulfonamido-2,3,4,5-tetrahydro-1h-benzo'diazepine derivatives with 5ht6 receptor affinity for the reatment of cns disorders HTR6, HTR7, HTR2A HTR6 1/4885HTR2C 6/4885DRD2 68/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.